Analyst Consensus ?
ConsensusHold29 ratings
Bullish517.3%
Neutral1758.6%
Bearish724.1%
Hormel Foods Corporation · HRL · FY2025 Q1 · Calendar Q1 2025
Hormel reaffirms FY2025 outlook as brands and modernization progress
The supplied analysis provides partial support for the view that resilient branded demand and productivity initiatives can support earnings, but the evidence is tempered by turkey supply-chain pressure, commodity inflation, and leadership-transition execution risk.
Reported Before market openNYSEConsumer Defensive
$10.57B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $0.38
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $2.95B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-1.2%
Event window
SPY move
-1.6%
Same window
Abnormal move
+0.4%
Stock minus SPY
Volume
1.4×
Versus trailing sessions
Subsequent drift
+6.8%
Up to 20 sessions
HRLSPY benchmark
Ask FN2 about HRL FY2025 Q1
Transcript, numbers and history already loaded
What drove HRL's -1.2% move after FY2025 Q1 earnings?What changed in HRL's guidance and outlook in FY2025 Q1?Give me the bull and bear case for HRL after FY2025 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The current analysis highlights 1% organic net sales growth, continued Planters recovery, and early benefits from Transform and Modernize. It also adds CEO succession as a monitoring item and says turkey constraints are being addressed with pricing actions aimed at improving second-half margins.
Guidance delta
Management reaffirmed FY2025 guidance for 1%-3% organic sales growth and adjusted EPS of $1.58-$1.72; no change was identified in the supplied analysis.
Key takeaways
- Organic net sales grew 1% in Q1, led by value-added brands and new product launches.
- Management said the Planters recovery is on track, supported by advertising and a multi-brand campaign.
- Transform and Modernize is expected to deliver $100-$150 million of value in 2025.
- Turkey supply-chain constraints remain a near-term pressure, with strategic pricing intended to support second-half margins.
- CEO succession planning and the Memphis distribution center add execution items to monitor.
Management priorities
- Support flagship brands and new product launches, including Spam, Applegate and Black Label Bacon.
- Scale the Here for the Snacks campaign with ESPN and maintain double-digit advertising growth.
- Manage turkey supply-chain constraints through pricing actions.
- Continue capital investment in capacity, infrastructure and technology.
- Complete the Memphis distribution center and advance Transform and Modernize.
Follow HRL with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$19.21Current
$23Low
$31.8Average
$54High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BNP Paribas | Neutral | Neutral | Maintain | Oct 7, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Aug 14, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jul 9, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jun 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Dec 9, 2025 |
| Piper Sandler | Neutral | Neutral | Maintain | Dec 5, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 30, 2025 |
| Citigroup | Buy | Buy | Maintain | Nov 19, 2024 |
| Argus Research | Hold | Buy | Downgrade | Mar 30, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Mar 3, 2023 |
| Seaport Global | Neutral | Neutral | Maintain | Sep 8, 2020 |
| CFRA | Hold | Hold | Maintain | May 21, 2020 |
| Bank of America | Underperform | Underperform | Maintain | Oct 25, 2019 |
| Buckingham Research | Neutral | Neutral | Maintain | May 24, 2019 |
| Jefferies | Hold | Buy | Downgrade | Nov 27, 2018 |
| Vertical Research | Sell | Hold | Downgrade | Nov 6, 2018 |
| Vertical Group | Sell | Hold | Downgrade | Nov 6, 2018 |
| BMO Capital | Market Perform | Outperform | Downgrade | Sep 17, 2018 |
| Buckingham | Neutral | Neutral | Maintain | Aug 16, 2018 |
| Mizuho | Underperform | Neutral | Downgrade | Jul 25, 2018 |
| Morgan Stanley | Underweight | Underweight | Maintain | Nov 3, 2017 |
| KeyBanc | Equal Weight | Sector Weight | Maintain | Dec 2, 2016 |
| Oppenheimer | Perform | Perform | Maintain | Sep 16, 2016 |
| Edward Jones | Buy | Hold | Upgrade | Sep 16, 2016 |
| BB&T Capital | Underweight | Hold | Downgrade | Apr 5, 2016 |
| CLSA | Underperform | Outperform | Downgrade | Feb 18, 2016 |
| Deutsche Bank | Hold | Hold | Maintain | Feb 17, 2016 |
| DA Davidson | Neutral | Neutral | Maintain | Nov 26, 2013 |
| Davenport | Buy | Neutral | Upgrade | Jul 1, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $19.21. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BNP Paribas | Max Gumport | $23 | $19.8 | +19.7% | Oct 7, 2026 |
| Stephens | Analyst unavailable | $23 | $21.28 | +19.7% | Aug 28, 2026 |
| Coker Palmer | Thomas Palmer | $26 | $24.44 | +35.3% | Aug 14, 2026 |
| Goldman Sachs | Analyst unavailable | $25 | $20.76 | +30.1% | May 21, 2026 |
| Stephens | Analyst unavailable | $22 | $20.76 | +14.5% | May 21, 2026 |
| Stephens | Analyst unavailable | $25 | $24.3 | +30.1% | Feb 11, 2026 |
| Barclays | Analyst unavailable | $30 | $23.85 | +56.2% | Dec 9, 2025 |
| Piper Sandler | Michael Lavery | $26 | $24.16 | +35.3% | Dec 5, 2025 |
| Coker Palmer | Thomas Palmer | $28 | $24.16 | +45.8% | Dec 4, 2025 |
| Goldman Sachs | Analyst unavailable | $27 | $21.49 | +40.6% | Oct 30, 2025 |
| Barclays | Benjamin Theurer | $34 | $25.69 | +77.0% | Aug 29, 2025 |
| Goldman Sachs | Analyst unavailable | $35 | $30.85 | +82.2% | Jun 23, 2025 |
| Piper Sandler | Michael Lavery | $33 | $32.53 | +71.8% | Dec 5, 2024 |
| BNP Paribas | Max Gumport | $28 | $32.19 | +45.8% | Oct 21, 2024 |
| Bank of America Securities | Peter Galbo | $30 | $31.01 | +56.2% | Sep 4, 2024 |
| Coker Palmer | Thomas Palmer | $37 | $31.25 | +92.6% | Aug 13, 2024 |
| Coker Palmer | Thomas Palmer | $29 | $30.79 | +51.0% | May 30, 2024 |
| Coker Palmer | Thomas Palmer | $35 | $35.47 | +82.2% | May 22, 2024 |
| Argus Research | Analyst unavailable | $54 | $45.55 | +181.1% | Dec 30, 2022 |
| J.P. Morgan | Analyst unavailable | $47 | $47.04 | +144.7% | Dec 1, 2022 |
| Argus Research | Analyst unavailable | $53 | $46.83 | +175.9% | Sep 22, 2022 |
| Stephens | Analyst unavailable | $55 | $50.72 | +186.3% | Aug 23, 2022 |
| Piper Sandler | Michael Lavery | $49 | $46 | +155.1% | Dec 10, 2021 |
Track every rating change on HRL the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationHormel Foods Corporation is a prominent global food company that specializes in the creation, preparation, and supply of a diverse array of meat, nut, and other culinary items. Its extensive clientele spans retail outlets, institutional food providers (foodservice), specialty delis, and various commercial enterprises across the United States and internationally. The company's operations are strategically structured into four main divisions: Grocery Products, Refrigerated Foods, Jennie-O Turkey Store, and International & Other. Hormel's product portfolio is broad, encompassing numerous perishable goods such as fresh meats, frozen food selections, convenient refrigerated meal options, a variety of sausages, hams, guacamole, and bacon. Additionally, it offers a wide range of non-perishable items, including canned luncheon meats, various nut butters, snack nuts, chili, microwave-ready meals, hashes, stews, tortillas, salsas, and tortilla chips.…
Historical context
All HRL earningsConsumer Defensive peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| PEP PepsiCo, Inc. | FY2026 Q3 · Calendar Q4 2026 | +2.2% | +3.7% | PepsiCo: International Growth Offsets U.S. Soft-Drink and Margin Pressure |
| STZ Constellation Brands, Inc. | FY2027 Q2 · Calendar Q4 2026 | +5.4% | +2.4% | Constellation Brands beats expectations and maintains FY27 EPS guidance |
| LW Lamb Weston Holdings, Inc. | FY2027 Q1 · Calendar Q4 2026 | +27.8% | +7.5% | Lamb Weston raises FY2027 outlook as North America volume growth continues |
| MKC McCormick & Company, Incorporated | FY2026 Q3 · Calendar Q4 2026 | +13.9% | -4.9% | McCormick reports strong Q3 growth while U.S. volumes remain soft |
| CAG Conagra Brands, Inc. | FY2027 Q1 · Calendar Q3 2026 | +44.4% | -4.9% | Conagra maintains outlook while increasing brand investment and simplifying SKUs |
| COST Costco Wholesale Corporation | FY2026 Q4 · Calendar Q3 2026 | +3.2% | +2.9% | Costco’s growth broadens as warehouses and digital sales accelerate |
Latest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the HRL recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-02-13T00:00:14.471520+00:00
- Polygon adjusted daily market bars · 2026-10-14T02:40:41.086236+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-14T02:40:41.083531+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-14. For educational purposes only; not investment advice.